文摘
Assays based on high-performance liquid chromatography (HPLC) and liquid chromatography tandem mass spectrometry (LC-MSn) have been developed and validated for the determination and metabolite identification of the bidesmosidic triterpenoid saponin, BTS-1 (3-O-¦Â-d-galactopyranosyl-(1¡ú2)-[¦Â-d-xylopyranosyl-(1¡ú3)]-¦Â-d-glucuronopyranosyl gypsogenin 28-O-¦Á-l-arabinopyranosyl-(1¡ú3)-¦Â-d-xylopyranosyl-(1¡ú4)-¦Á-l-rhamnopyranosyl-(1¡ú2)-¦Â-d-fucopyranoside), in rat plasma. The assay was successfully applied to a pharmacokinetic study in rats given a single oral dose of BTS-1 (400 mg/kg). The results indicated that the compound was rapidly absorbed (Tmax=1.28¡À0.29 h, Cmax=37.4¡À5.6 ¦Ìg/mL) and slowly eliminated (t1/2=13.2¡À6.6 h). In addition, secondary glycosides and aglycones of BTS-1 were detected and identified. Since these metabolites are known to be active ¦Á-glucosidase inhibitors, they probably play an important role in mediating the pharmacological effects of the saponin.